|
1
|
Rachner TD, Khosla S and Hofbauer LC:
Osteoporosis: Now and the future. Lancet. 377:1276–1287. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weitzmann MN and Pacifici R: Estrogen
deficiency and bone loss: An inflammatory tale. J Clin Invest.
116:1186–1194. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roggia C, Gao Y, Cenci S, Weitzmann MN,
Toraldo G, Isaia G and Pacifici R: Up-regulation of TNF-producing T
cells in the bone marrow: A key mechanism by which estrogen
deficiency induces bone loss in vivo. Proc Natl Acad Sci USA.
98:13960–13965. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duque G, Huang DC, Dion N, Macoritto M,
Rivas D, Li W, Yang XF, Li J, Lian J, Marino FT, et al:
Interferon-γ plays a role in bone formation in vivo and rescues
osteoporosis in ovariectomized mice. J Bone Min Res. 26:1472–1483.
2011. View
Article : Google Scholar
|
|
5
|
Cenci S, Toraldo G, Weitzmann MN, Roggia
C, Gao Y, Qian WP, Sierra O and Pacifici R: Estrogen deficiency
induces bone loss by increasing T cell proliferation and lifespan
through IFN-gamma-induced class II transactivator. Proc Natl Acad
Sci USA. 100:10405–10410. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kudo O, Sabokbar A, Pocock A, Itonaga I,
Fujikawa Y and Athanasou NA: Interleukin-6 and interleukin-11
support human osteoclast formation by a RANKL-independent
mechanism. Bone. 32:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hartgring SAY, Bijlsma JWJ, Lafeber FPJG
and van Roon JAG: Interleukin-7 induced immunopathology in
arthritis. Ann Rheumatic Dis. 65:iii69–iii74. 2006. View Article : Google Scholar
|
|
8
|
Han X, Kawai T, Eastcott JW and Taubman
MA: Bacterial-Responsive B Lymphocytes Induce Periodontal Bone
Resorption. J Immunol. 176:625–631. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu J and Paul WE: CD4 T cells: fates,
functions, and faults. Blood. 112:1557–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kikuta J, Wada Y, Kowada T, Wang Z,
Sun-Wada GH, Nishiyama I, Mizukami S, Maiya N, Yasuda H, Kumanogoh
A, et al: Dynamic visualization of RANKL and Th17-mediated
osteoclast function. J Clin Invest. 123:866–873. 2003.
|
|
11
|
Griffith TS, Brunner T, Fletcher SM, Green
DR and Ferguson TA: Fas ligand-induced apoptosis as a mechanism of
immune privilege. Science. 270:1189–1192. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Siegel RM, Frederiksen JK, Zacharias DA,
Chan FK, Johnson M, Lynch D, Tsien RY and Lenardo MJ: Fas
preassociation required for apoptosis signaling and dominant
inhibition by pathogenic mutations. Science. 288:2354–2357. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakamura T, Imai Y, Matsumoto T, Sato S,
Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, et
al: Estrogen prevents bone loss via estrogen receptor alpha and
induction of fas ligand in osteoclasts. Cell. 130:811–823. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krum SA, Miranda-Carboni GA, Hauschka PV,
Carroll JS, Lane TF, Freedman LP and Brown M: Estrogen protects
bone by inducing Fas ligand in osteoblasts to regulate osteoclast
survival. EMBO J. 27:535–545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krampera M, Glennie S, Dyson J, Scott D,
Laylor R, Simpson E and Dazzi F: Bone marrow mesenchymal stem cells
inhibit the response of naive andmemory antigen-specific T cells to
their cognate peptide. Blood. 101:3722–3729. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rosado MM, Bernardo ME, Scarsella M,
Conforti A, Giorda E, Biagini S, Cascioli S, Rossi F, Guzzo I,
Vivarelli M, et al: Inhibition of B-cell proliferation and antibody
production by mesenchymal stromal cells is mediated by T cells.
Stem Cells. 24:93–103. 2015. View Article : Google Scholar
|
|
17
|
Schurgers E, Kelchtermans H, Mitera T,
Geboes L and Matthys P: Discrepancy between the in vitro and in
vivoeffects of murine mesenchymal stem cells onT-cell proliferation
and collagen-induced arthritis. Arthritis Res Ther. 12:R312003.
View Article : Google Scholar
|
|
18
|
Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z,
Zhao L, Nagy TR, Peng X, Hu J, et al: TGF-beta1-induced migration
of bone mesenchymal stem cells couples bone resorption with
formation. Nat Med. 15:757–765. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao H, Xu H and Xue L: Regulatory network
involving miRNAs and genes in serous ovarian carcinoma. Oncol Lett.
14:6259–6268. 2007.
|
|
20
|
Sugatani T and Hruska KA: Down-regulation
of miR-21 biogenesis by estrogen action contributes to osteoclastic
apoptosis. J Cell Biochem. 114:1217–1222. 2003. View Article : Google Scholar
|
|
21
|
Shao B, Liao L, Yu Y, Shuai Y, Su X, Jing
H, Yang D and Jin Y: Estrogen preserves Fas ligand levels by
inhibiting microRNA-181a in bone marrow-derived mesenchymal stem
cells to maintain bone remodeling balance. FASEB J. 29:3935–3944.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bolstad BM, Irizarry RA, Astrand M and
Speed TP: A comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinformatics. 19:185–193. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akiyama K, Chen C, Wang D, Xu X, Qu C,
Yamaza T, Cai T, Chen W, Sun L and Shi S:
Mesenchymal-stem-cell-induced immunoregulation involves
FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell.
10:544–555. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang N, Wang G, Hu C, Shi Y, Liao L, Shi
S, Cai Y, Cheng S, Wang X, Liu Y, et al: Tumor necrosis factor α
suppresses the mesenchymal stem cell osteogenesis promoter miR-21
in estrogen deficiency-induced osteoporosis. J Bone Miner Res.
28:559–573. 2003. View Article : Google Scholar
|
|
26
|
Hsu H, Lacey DL, Dunstan CR, Solovyev I,
Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, et
al: Tumor necrosis factor receptor family member RANK mediates
osteoclast differentiation and activation induced by
osteoprotegerin ligand. Proc Natl Acad Sci USA. 96:3540–3545. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mor G, Kohen F, Garcia-Velasco J, Nilsen
J, Brown W, Song J and Naftolin F: Regulation of Fas ligand
expression in breast cancer cells by estrogen: Functional
differences between estradiol and tamoxifen. J Steroid Biochem Mol
Biol. 73:185–194. 2003. View Article : Google Scholar
|
|
28
|
Cohen A, Shmoish M, Levi L, Cheruti U,
Levavi-Sivan B and Lubzens E: Alterations in Micro-ribonucleic acid
expression profiles reveal a novel pathway for estrogen regulation.
Endocrinology. 149:1687–1696. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kovalchuk O, Tryndyak VP, Montgomery B,
Boyko A, Kutanzi K, Zemp F, Warbritton AR, Latendresse JR,
Kovalchuk I, Beland FA and Pogribny IP: Estrogen-induced rat breast
carcinogenesis is characterized by alterations in DNA methylation,
histone modifications, and aberrant microrna expression. Cell
Cycle. 6:2010–2018. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai R, Phillips RA, Zhang Y, Khan D,
Crasta O and Ahmed SA: Suppression of LPS-induced Interferon-gamma
and nitric oxide in splenic lymphocytes by select
estrogen-regulated microRNAs: A novel mechanism of immune
modulation. Blood. 112:4591–4597. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo L, Xu J, Qi J, Zhang L, Wang J, Liang
J, Qian N, Zhou H, Wei L and Deng L: MicroRNA-17-92a upregulation
by estrogen leads to Bim targeting and inhibition of osteoblast
apoptosis. J Cell Sci. 126:978–988. 2003. View Article : Google Scholar
|
|
32
|
Naguibneva I, Ameyar-Zazoua M, Polesskaya
A, Ait-Si-Ali S, Groisman R, Souidi M, Cuvellier S and Harel-Bellan
A: The microRNA miR-181 targets the homeobox protein Hox-A11 during
mammalian myoblast differentiation. Nat Cell Biol. 8:278–284. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kumar S, Naqvi RA, Khanna N and Rao DN:
Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b
cross-talk and miR181a towards T cell hyporesponsiveness in
leprosy. Mol Immunol. 48:1178–1190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li YG, Zhang PP, Jiao KL and Zou YZ:
Knckdown of microRNA-181 by lentivirus mediated siRNA expression
vector decreases the arrhythmogenic effect of skeletal myoblast
transplantation in rat with mycardial infarction. Microvasc Res.
78:393–404. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ouyang YB, Lu Y, Yue S, Xu LJ, Xiong XX,
White RE, Sun X and Giffard RG: miR-181 regulates GRP78 and
influences outcome from cerebral ischemia in vitro and in vivo.
Neurobiol Dis. 45:555–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu X, Zhang X, Dhakal IB, Beggs M,
Kadlubar S and Luo D: Induction of cell proliferation and survival
genes by estradiol-repressed microRNAs in breast cancer cells. BMC
Cancer. 12:292012. View Article : Google Scholar : PubMed/NCBI
|
